Key Points

India's MedTech industry is poised for significant transformation with ambitious global market expansion plans. The CII-BCG report highlights the sector's potential to reduce import dependency and become a global manufacturing hub. Currently valued at $16 billion, the industry aims to increase its global market share from 2% to 10-12% by 2047. Strategic government initiatives and collaborative efforts are key to achieving these transformative goals.

Key Points: India MedTech Growth Targets Global Market Dominance

  • CII report highlights India's $16 billion MedTech industry potential
  • Government aims to reduce import dependency below 50%
  • Strategic initiatives planned to boost manufacturing ecosystem
  • Targeting 10-12% global market share by 2047
2 min read

Indian MedTech industry crucial to reduce import dependency, boost global market share: Report

CII-BCG report reveals India's strategic plan to reduce medical import dependency and expand global MedTech manufacturing presence by 2047

"With concerted government, industry, and academic collaboration, India can position itself as a trusted global hub for MedTech manufacturing and innovation - CII-BCG Report"

New Delhi, Aug 29

India's MedTech industry is strategic to reduce the import dependency as well as boost the sector's share in the global market, according to a report on Friday.

The report by the Confederation of Indian Industry (CII), in collaboration with Boston Consulting Group (BCG), highlights the transformative opportunity for India's MedTech industry to emerge as a global manufacturing and innovation hub.

The CII-BCG report was launched at the inaugural session of the 17th CII Global MedTech Summit by Amit Agrawal, Secretary, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers.

Valued at approximately $16 billion, India's MedTech industry currently accounts for only around 2per cent of the approximately $680 billion global market.

"With the government's Viksit Bharat 2047 vision, the sector has been identified as a strategic pillar in the 'Make in India' agenda, with aspirations to reduce import dependency to below 50per cent and increase India's share of the global market to 10-12per cent," the report said.

It noted that India has made significant strides in building MedTech manufacturing capacity. The achievements include the development of four MedTech parks, led by Andhra Pradesh MedTech Zone (AMTZ) as the most advanced, financial incentives such as the Production-Linked Incentive (PLI) scheme, and state-level tax benefits.

Further, it also led to upskilling initiatives through institutions like NIPER to develop MedTech talent and paved the way for rising private investments from both domestic players and global MNCs, reducing import reliance from about 80 per cent in FY2022 to nearly 60per cent in FY2024.

"Despite the progress, the report identifies key challenges to achieving manufacturing excellence: gaps in the ecosystem for high-end devices, regulatory complexity, shortage of skilled manpower, under-utilisation of MedTech parks, and limited MSME participation in incentive schemes," the report said.

To address these, the report outlined strategic initiatives to drive the next phase of growth, such as fine-tuning the PLI scheme for MSME participation, rationalising import duties and duty exemptions for critical raw materials.

It suggested developing a raw material ecosystem; attracting MNC manufacturing and R&D hubs to India; and unlocking the potential of MedTech parks through co-innovation labs and shared foundries.

"With concerted government, industry, and academic collaboration, India can not only meet growing domestic demand but also position itself as a trusted global hub for MedTech manufacturing and innovation," the report said.

- IANS

Share this article:

Reader Comments

P
Priya S
As someone working in healthcare, I've seen how expensive imported medical devices are. Local manufacturing will make quality healthcare more affordable for common people. Hope the government addresses the skilled manpower shortage quickly.
A
Amit G
The MSME participation issue is crucial. Small manufacturers need better support and simpler regulations to contribute meaningfully. Otherwise, only big companies will benefit from these schemes.
S
Sarah B
Working with Indian MedTech companies from the US, I can see the incredible potential. The quality is improving rapidly, and with proper R&D investment, India can become a global hub. The talent pool here is exceptional!
N
Nikhil C
Hope they focus on indigenous R&D rather than just assembly manufacturing. We need to develop our own IP and technologies, not just make foreign designs cheaper. That's real Atmanirbhar Bharat! 💪
K
Kavya N
The MedTech parks need better utilization. I visited AMTZ last year - great infrastructure but many units were underutilized. Government should provide better marketing support to these manufacturers to find global buyers.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50